STRS Ohio’s Atea Pharmaceuticals AVIR Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $409K | Buy |
113,500
+8,000
| +8% | +$28.8K | ﹤0.01% | 1399 |
|
2025
Q1 | $315K | Hold |
105,500
| – | – | ﹤0.01% | 1384 |
|
2024
Q4 | $353K | Hold |
105,500
| – | – | ﹤0.01% | 1326 |
|
2024
Q3 | $353K | Hold |
105,500
| – | – | ﹤0.01% | 1399 |
|
2024
Q2 | $349K | Buy |
105,500
+10,800
| +11% | +$35.7K | ﹤0.01% | 1388 |
|
2024
Q1 | $382K | Sell |
94,700
-6,000
| -6% | -$24.2K | ﹤0.01% | 1362 |
|
2023
Q4 | $307K | Hold |
100,700
| – | – | ﹤0.01% | 1451 |
|
2023
Q3 | $302K | Hold |
100,700
| – | – | ﹤0.01% | 1452 |
|
2023
Q2 | $376K | Buy |
100,700
+5,500
| +6% | +$20.5K | ﹤0.01% | 1393 |
|
2023
Q1 | $318K | Sell |
95,200
-32,700
| -26% | -$109K | ﹤0.01% | 1485 |
|
2022
Q4 | $615K | Buy |
127,900
+36,800
| +40% | +$177K | ﹤0.01% | 1197 |
|
2022
Q3 | $518K | Sell |
91,100
-3,900
| -4% | -$22.2K | ﹤0.01% | 1317 |
|
2022
Q2 | $674K | Sell |
95,000
-28,700
| -23% | -$204K | ﹤0.01% | 1166 |
|
2022
Q1 | $893K | Buy |
123,700
+25,700
| +26% | +$186K | ﹤0.01% | 1106 |
|
2021
Q4 | $876K | Buy |
98,000
+60,200
| +159% | +$538K | ﹤0.01% | 1196 |
|
2021
Q3 | $1.33M | Buy |
37,800
+700
| +2% | +$24.5K | 0.01% | 938 |
|
2021
Q2 | $796K | Buy |
37,100
+28,900
| +352% | +$620K | ﹤0.01% | 1341 |
|
2021
Q1 | $506K | Buy |
8,200
+4,700
| +134% | +$290K | ﹤0.01% | 1566 |
|
2020
Q4 | $146K | Buy |
+3,500
| New | +$146K | ﹤0.01% | 1812 |
|